Expert Commentary

Which treatments for pelvic floor disorders are backed by evidence?

Author and Disclosure Information

 

References

Adverse events after surgical procedures for pelvic floor disorders. In Scotland, Morling and colleagues performed a retrospective observational cohort study of first-time surgeries for SUI (mesh or colposuspension; 16,660 procedures) and prolapse (mesh or native tissue; 18,986 procedures).

After 5 years of follow-up, women who underwent midurethral mesh sling placement or colposuspension had similar rates of repeat surgery for recurrent SUI (adjusted incidence rate ratio, 0.90; 95% CI, 0.73–1.11). Use of mesh slings was associated with fewer immediate complications (adjusted relative risk, 0.44; 95% CI, 0.36–0.55) compared with nonmesh surgery.

Among women who underwent surgery for prolapse, those who had anterior and posterior repair with mesh experienced higher late complication rates than those who underwent native tissue repair. Risk for subsequent prolapse repair was similar with mesh and native-tissue procedures.

Authors’ commentary. The researchers noted that their data support the use of mesh procedures for incontinence but additional research on longer-term outcomes would be useful. However, for prolapse repair, the study results do not decidedly favor any one vault repair procedure.

WHAT THIS EVIDENCE MEANS FOR PRACTICEThese studies highlight the prevalence of pelvic floor disorders and underscore the need for evidence-based treatment strategies. Women with symptomatic pelvic floor disorders initially should be offered conservative options and education. Although mesh grafts certainly have expanded the surgical options for managing pelvic floor disorders, they should be used with caution transvaginally for primary prolapse repairs. Because of the complexity of POP and its treatment, it is reasonable to refer patients with the condition to a specialist experienced in female pelvic medicine and reconstructive surgery.
--Meadow M. Good, DO

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Pages

Recommended Reading

Absorbable suture performs well in sacrocolpopexy with mesh
MDedge ObGyn
Incontinence trial finds small advantage for Botox over sacral neuromodulation
MDedge ObGyn
Botox for overactive bladder led to low rate of catheterization
MDedge ObGyn
Laparoscopic sacrocolpopexy offers advantages over abdominal route
MDedge ObGyn
Fluorescein, 10% dextrose topped other media for visualizing ureteral patency
MDedge ObGyn
Cough harder during stress urinary incontinence testing, study suggests
MDedge ObGyn
POP severity not linked to risk of de novo stress urinary incontinence
MDedge ObGyn
No rise in complications with concomitant gynecologic cancer, PFD surgery
MDedge ObGyn
Registry helps track pelvic organ prolapse outcomes in the U.S.
MDedge ObGyn
2016 Update on pelvic floor dysfunction
MDedge ObGyn